Autocrine/paracrine function of globular adiponectin: Inhibition of lipid metabolism and inflammatory response in 3t3-l1 adipocytes

Journal of Cellular Biochemistry

Volumn 116, Issue 5, 2015, Pages 754-766

  Lazra, Yulia ^a,b   Falach, Alona ^a,b   Frenkel, Lital ^a,b   Rozenberg, Konstantin ^a   Sampson, Sanford ^b,c   Rosenzweig, Tovit ^a  

^a ARIEL UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

ADIPOCYTE; DIFFERENTIATION; GLOBULAR ADIPONECTIN; INFLAMMATION

Indexed keywords

ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 2; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; FATTY ACID BINDING PROTEIN 4; GLOBULAR ADIPONECTIN; GLUCOSE TRANSPORTER 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; ADIPONECTIN RECEPTOR;

3T3 CELL LINE; ADIPOCYTE; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCOSE TRANSPORT; INFLAMMATION; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; ANIMAL; DRUG EFFECTS; INSULIN RESISTANCE; METABOLISM; MOUSE;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; MICE; PARACRINE COMMUNICATION; RECEPTORS, ADIPONECTIN;

EID: 84924326269     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25031     Document Type: Article

References (50)

1. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y,. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
2. Asterholm IW, Scherer PE,. 2010. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 176: 1364-1376.
3. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kubota N, Kaneko K, Kobayashi M, Iwane A, Sasako T, Okazaki Y, Ohsugi M, Takamoto I, Yamashita S, Asahara H, Akira S, Kasuga M, Kadowaki T,. 2011. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 13: 401-412.
4. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE,. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953.
5. Berg AH, Combs TP, Scherer PE,. 2002. ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13: 84-89.
6. Bluher M,. 2012. Clinical relevance of adipokines. Diabetes Metab J 36: 317-327.
7. Chetboun M, Abitbol G, Rozenberg K, Rozenfeld H, Deutsch A, Sampson SR, Rosenzweig T,. 2012. Maintenance of redox state and pancreatic beta-cell function: Role of leptin and adiponectin. J Cell Biochem 113: 1966-1976.
8. Cristancho AG, Lazar MA,. 2011. Forming functional fat: A growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12: 722-734.
9. Frost SC, Lane MD,. 1985. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem 260: 2646-2652.
10. Fu Y, Luo N, Klein RL, Garvey WT,. 2005. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 46: 1369-1379.
11. Furuhashi M, Hotamisligil GS,. 2008. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7: 489-503.
12. Gu W, Li Y,. 2012. The therapeutic potential of the adiponectin pathway. Bio Drugs 26: 1-8.
13. Hashizume M, Yoshida H, Koike N, Suzuki M, Mihara M,. 2010. Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor. Ann Rheum Dis 69: 741-746.
14. Hoch M, Eberle AN, Peterli R, Peters T, Seboek D, Keller U, Muller B, Linscheid P,. 2008. LPS induces interleukin-6 and interleukin-8 but not tumor necrosis factor-alpha in human adipocytes. Cytokine 41: 29-37.
15. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, Davis KE, Bikman BT, Halberg N, Rutkowski JM, Wade MR, Tenorio VM, Kuo MS, Brozinick JT, Zhang BB, Birnbaum MJ, Summers SA, Scherer PE,. 2011. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17: 55-63.
16. Huypens P, Moens K, Heimberg H, Ling Z, Pipeleers D, Van de Casteele M,. 2005. Adiponectin-mediated stimulation of AMP-activated protein kinase (AMPK) in pancreatic beta cells. Life Sci 77: 1273-1282.
17. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I,. 2003. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52: 1655-1663.
18. Janesick A, Blumberg B,. 2011. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 93: 34-50.
19. Kadowaki T, Yamauchi T,. 2005. Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451.
20. Kajita K, Mori I, Kitada Y, Taguchi K, Kajita T, Hanamoto T, Ikeda T, Fujioka K, Yamauchi M, Okada H, Usui T, Uno Y, Morita H, Ishizuka T,. 2013. Small proliferative adipocytes: Identification of proliferative cells expressing adipocyte markers [Review]. Endocr J 60: 931-939.
21. MacKellar J, Cushman SW, Periwal V,. 2009. Differential effects of thiazolidinediones on adipocyte growth and recruitment in Zucker fatty rats. PLoS One 4: e8196.
22. Miller RA, Chu Q, Le Lay J, Scherer PE, Ahima RS, Kaestner KH, Foretz M, Viollet B,. 2011. Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. and M J Birnbaum 121: 2518-2528.
23. Mlinar B, Marc J,. 2011. New insights into adipose tissue dysfunction in insulin resistance. Clin Chem Lab Med 49: 1925-1935.
24. Ntambi JM, Young-Cheul K,. 2000. Adipocyte differentiation and gene expression. J Nutr 130: 3122S-3126S.
25. O'Connell J, Lynch L, Cawood TJ, Kwasnik A, Nolan N, Geoghegan J, McCormick A, O'Farrelly C, O'Shea D,. 2010. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS ONE 5: e9997.
26. Palanivel R, Fang X, Park M, Eguchi M, Pallan S, De Girolamo S, Liu Y, Wang Y, Xu A, Sweeney G,. 2007. Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes. Cardiovasc Res 75: 148-157.
27. Pereira RI, Wang CC, Hosokawa P, Dickinson LM, Chonchol M, Krantz MJ, Steiner JF, Bessesen DH, Havranek EP, Long CS,. 2011. Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures. BMC Endocr Disord 11: 13.
28. Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM, Rasmussen M, Richelsen B,. 2006. Adiponectin receptors in human adipose tissue: Effects of obesity, weight loss, and fat depots. Obesity (Silver Spring) 14: 28-35.
29. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D,. 2003. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26: 2383-2388.
30. Sell H, Habich C, Eckel J,. 2012. Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8: 709-716.
31. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ,. 2008. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118: 1645-1656.
32. Shetty S, Ramos-Roman MA, Cho YR, Brown J, Plutzky J, Muise ES, Horton JD, Scherer PE, Park EJ,. 2012. Enhanced fatty acid flux triggered by adiponectin overexpression. Endocrinology 153: 113-122.
33. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K,. 2005. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103.
34. Sieuwerts AM, Klijn JG, Peters HA, Foekens JA,. 1995. The MTT tetrazolium salt assay scrutinized: How to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics. Eur J Clin Chem Clin Biochem 33: 813-823.
35. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang C, Itani SI, Lodish HF, Ruderman NB,. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 99: 16309-16313.
36. Turer AT, Browning JD, Ayers CR, Das SR, Khera A, Vega GL, Grundy SM, Scherer PE,. 2012. Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study. J Clin Endocrinol Metab 97: E982-E986.
37. Turer AT, Scherer PE,. 2012. Adiponectin: Mechanistic insights and clinical implications. Diabetologia 55: 2319-2326.
38. Turner JJ, Smolinska MJ, Sacre SM, Foxwell BM,. 2009. Induction of TLR tolerance in human macrophages by adiponectin: Does LPS play a role. Scand J Immunol 69: 329-336.
39. Vega RB, Huss JM, Kelly DP,. 2000. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20: 1868-1876.
40. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO,. 2002. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79.
41. Wedellova Z, Kovacova Z, Tencerova M, Vedral T, Rossmeislova L, Siklova-Vitkova M, Stich V, Polak J,. 2013. The impact of full-length, trimeric and globular adiponectin on lipolysis in subcutaneous and visceral adipocytes of obese and non-obese women. PLoS ONE 8: e66783.
42. Wijesekara N, Krishnamurthy M, Bhattacharjee A, Suhail A, Sweeney G, Wheeler MB,. 2010. Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J Biol Chem 285: 33623-33631.
43. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ,. 2003. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52: 1355-1363.
44. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME,. 2004. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316: 924-929.
45. Yamauchi T, Kadowaki T,. 2008. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond) 32: S13-S18.
46. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T,. 2003a. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769.
47. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T,. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
48. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T,. 2003b. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468.
49. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y,. 2000. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96: 1723-1732.
50. Zoico E, Garbin U, Olioso D, Mazzali G, Fratta AM, Di Francesco V, Sepe A, Cominacini L, Zamboni M,. 2009. The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: Role of the NF-kappaB pathway. Int J Mol Med 24: 847-851.